Biotech stocks posted losses for the third straight week, as the sector reacted to broader market weakness and announcements out of the 2022 JPMorgan Healthcare conference. Here are the key catalysts that could move stocks in the unfolding week.

The biopharma sector weathered the COVID-19 pandemic fairly well, with the Shares Nasdaq Biotechnology ETF IBB outperforming the S&P 500 Index. Here are the biotechs that advanced in excess of 1,000% thus far this year:

Here's a roundup of top developments in the biotech space over the last 24 hours.

Covering today's biggest news in biotech, including upcoming IPO's and which stocks are hitting their 52 week high and lows.